Chromocell Therapeutics Corp - CHRO Sotuvning operatsion marjasi

Chromocell (CHRO) kompaniyasining korporativ logotipi

Yuqori ilmiy nufuz va doimiy talabga ega bo'lgan opioid bo'lmagan og'riq qoldiruvchi vositalarning ishlab chiqilishi Chromocell Therapeutics (CHRO) uchun barqaror daromadni ta'minlaydi. EBIT ga asoslangan operatsion rentabellik asosiy faoliyatdan olingan foyda dinamikasini aks ettiradi, bunda joriy daraja 0.00 ni tashkil etadi. Biznes samaradorligi yangi dori vositalarini kashf qilishni avtomatlashtiruvchi va dori preparatlarining chiqarilishini tezlashtiruvchi robotlashtirilgan platforma orqali oshirilgan.

CHRO: chromocell.com Operatsion foyda normasi 21.02.2024 - 02.07.2025

Chromocell Therapeutics - tahliliy kesimlar va asosiy koʻrsatkichlar (CHRO)

- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning asosiy tahlili:CHRO, Chromocell Therapeutics Corp.
Chromocell asosiy tovari

Chromocell Therapeutics (CHRO) kompaniyasining opioid bo'lmagan og'riq qoldiruvchi vositalarni ishlab chiqish uchun R&D laboratoriyalarining rejalashtirilgan quvvatdan foydalanish darajasi kompaniyaning joriy xarajatlar tuzilmasini belgilaydi. EBIT orqali operatsion rentabellikni tahlil qilish orqali investor asosiy biznes foydasining umumiy daromadga nisbatini baholaydi, bu esa ushbu ko'rsatkichga kapital samaradorligini va biznes qiymatidagi fundamental o'zgarishlarning absorbsiya qilinish tezligini o'lchash imkonini beradi.

Chromocell Therapeutics kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi BIIB|NBIX: Operatsion foyda normasi|Operatsion rentabellik Regencell Bioscience Ltd (RGC)|Operatsion marja axsome.com (AXSM)|Operatsion marja ACAD (acadia-pharm.com)|XENE - Sotuvning operatsion marjasi|vikingtherapeutics.com - Operatsion marja|Supernus Pharma (SUPN) - Sotuvning operatsion marjasi|CPRX: Operatsion marja|Denali Therapeutics Inc. (DNLI) - Operatsion marja|Operatsion rentabellik Harmony Pharma|Operatsion rentabellik BHVN|Sotuvning operatsion marjasi AMLX (Amylyx Pharmaceuticals, Inc.)|Sotuvning operatsion marjasi Trevi Corp TRVI|Operatsion rentabellik praxismedicines.com PRAX|AVXL - Sotuvning operatsion marjasi|CeriBell EEG - Operatsion marja|Sotuvning operatsion rentabelligi prothena.com|Alector Therapeutics (ALEC) - Operatsion rentabellik|Annexon Biosciences Inc. - Operatsion foyda normasi|OMER (Omeros Corp) - Operatsion marja|Operatsion marja neurogene.com|Operatsion marja ACIU|VYGR - Sotuvning operatsion rentabelligi|Operatsion rentabellik Neumora Therapeutics Inc NMRA|Operatsion faoliyat rentabelligi Scilex Holding Co. (SCLX)|TVGN - Operatsion rentabellik|Sotuvning operatsion rentabelligi alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Sotuvning operatsion marjasi|IKT: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Cassava Sciences, Inc.|ASRT (assertiotx.com) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Coya (COYA)|VTGN - Sotuvning operatsion rentabelligi|Operatsion marja OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Sotuvning operatsion rentabelligi|cervomed.com - Operatsion marja|Operatsion foyda normasi ATHE (Alterity Therapeutics Limited)|CLNN: Operatsion marja|Sotuvning operatsion marjasi PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Relmada Therapeutics Inc RLMD|Operatsion rentabellik Annovis Bio Corporation (ANVS)|GRCE - Sotuvning operatsion rentabelligi|Operatsion rentabellik Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Sotuvning operatsion rentabelligi|NeuroSense Therapeutics, Ltd. - Operatsion marja|RVPH: Operatsion rentabellik|MTVA: Operatsion marja|NRXS - Operatsion faoliyat rentabelligi|HSDT (Helius Medical Technologies Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Passage Bio PASG|Operatsion rentabellik Neuphoria (NEUP)|Operatsion marja Minerva Neurosciences Corp (NERV)|Operatsion rentabellik Athira ATHA|Operatsion marja Addex ADXN|Alzamend - Operatsion marja|Sotuvning operatsion rentabelligi Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Operatsion rentabellik|KTTA: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi CRGT|Avenue Therapeutics, Inc - Operatsion foyda marjasi|Operatsion rentabellik Brainstorm Cell (BCLI)|CARA: Operatsion foyda marjasi|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi